Cornejo-Olivas, Mario
Solis-Ponce, Lesly
Araujo-Aliaga, Ismael
Milla-Neyra, Karina
Ortega, Olimpio
Illanes-Manrique, Maryenela
Mazzetti, Pilar
Manrique-Enciso, Carla
Cubas-Montecino, Diana
Saraiva-Pereira, Maria Luiza
Jardim, Laura B.
Sarapura-Castro, Elison
Funding for this research was provided by:
PROCIENCIA-CONCYTEC (098-2017-FONDECYT, 098-2017-FONDECYT, 148-2020-PROCIENCIA, 098-2017-FONDECYT, 098-2017-FONDECYT, 098-2017-FONDECYT, 098-2017-FONDECYT, 098-2017-FONDECYT, 098-2017-FONDECYT, 098-2017-FONDECYT)
Article History
Accepted: 21 October 2022
First Online: 3 November 2022
Declarations
:
: The study was approved by the Ethics Committee at INCN, called the “<i>Comité Institucional de Ética en Investigación del Instituto Nacional de Ciencias Neurológicas</i>,” IRB number 486–2018-CIEI-INCN. All patients provided written informed consent for use of their genetic and clinical data for anonymized research studies at the time of their genetic testing. We confirm that we have read the Journal’s position on issues involved in ethical publication and affirm that this work is consistent with those guidelines.
: The authors declare no competing interests.